Melissa Kotterman
Private Equity Investor bei Berkeley Frontier Fund
Profil
Melissa Kotterman is the founder of 4D Molecular Therapeutics, Inc. which was founded in 2013.
She held the title of Vice President-Discovery & Engineering from 2013 to 2021.
Dr. Kotterman is also the founder of Ignite Immunotherapy, Inc. Currently, she is a Venture Partner at Berkeley Frontier Fund.
Dr. Kotterman received an undergraduate degree from Carnegie Mellon University and a doctorate degree from the University of California, Berkeley in 2013.
Aktive Positionen von Melissa Kotterman
| Unternehmen | Position | Beginn |
|---|---|---|
Berkeley Frontier Fund
 Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Melissa Kotterman
| Unternehmen | Position | Ende |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Gründer | 01.11.2021 |
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Gründer | - |
Ausbildung von Melissa Kotterman
| Carnegie Mellon University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Health Technology |
Berkeley Frontier Fund
Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Finance |
